Takeda Pharmaceutical Company Limited
NYSE: TAK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Christophe Weber
- Employees
- 49,281
- Headquarters
- Tokyo, Japan
- IPO year
- 2010
- Market cap
- $49.4B
- Website
- https://www.takeda.com
Loading TAK…
Loading profile data…Frequently asked questions about TAK
What does Takeda Pharmaceutical Company Limited (TAK) do?
Takeda Pharmaceutical Company Limited is a prominent global biopharmaceutical entity dedicated to the discovery, development, manufacturing, commercialization, and out-licensing of pharmaceutical products. The company's operations extend across a vast international footprint, encompassing Japan, the United States, Europe, Canada, Latin America,...
Where does TAK trade?
Takeda Pharmaceutical Company Limited (TAK) trades on the New York Stock Exchange.
What sector is TAK in?
Takeda Pharmaceutical Company Limited (TAK) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Takeda Pharmaceutical Company Limited?
Christophe Weber is the chief executive officer of Takeda Pharmaceutical Company Limited (TAK).
Where is Takeda Pharmaceutical Company Limited headquartered?
Takeda Pharmaceutical Company Limited is headquartered in Japan.
Does TAK pay a dividend?
Yes — Takeda Pharmaceutical Company Limited (TAK) paid a trailing twelve-month dividend of USD 0.62 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did TAK go public?
Takeda Pharmaceutical Company Limited (TAK) completed its initial public offering in 2010.
Is TAK an ADR?
Yes — TAK is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Takeda Pharmaceutical Company Limited reporting and dividends follow the underlying issuer.